These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31782051)

  • 1. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor.
    Heitzer AM; Villagran AM; Raghubar K; Brown AL; Camet ML; Ris MD; Hanning JH; Okcu MF; Paulino AC; Chintagumpala M; Kahalley LS
    J Neurooncol; 2020 Jan; 146(1):147-156. PubMed ID: 31782051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
    Moxon-Emre I; Dahl C; Ramaswamy V; Bartels U; Tabori U; Huang A; Cushing SL; Papaioannou V; Laperriere N; Bouffet E; Mabbott DJ
    Cancer Med; 2021 Oct; 10(20):7111-7125. PubMed ID: 34480430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.
    Orgel E; O'Neil SH; Kayser K; Smith B; Softley TL; Sherman-Bien S; Counts PA; Murphy D; Dhall G; Freyer DR
    Pediatr Blood Cancer; 2016 Mar; 63(3):527-34. PubMed ID: 26529035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy.
    Roth AK; Ris MD; Orobio J; Xue J; Mahajan A; Paulino AC; Grosshans D; Okcu MF; Chintagumpala M; Kahalley LS
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28064. PubMed ID: 31736188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors.
    Mizumoto M; Oshiro Y; Pan H; Wang F; Kaste SC; Gajjar A; Chemaitilly W; Merchant TE
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28617. PubMed ID: 32715632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Implications of Ototoxicity in Pediatric Patients With Embryonal Brain Tumors.
    Olivier TW; Bass JK; Ashford JM; Beaulieu R; Scott SM; Schreiber JE; Palmer S; Mabbott DJ; Swain MA; Bonner M; Boyle R; Chapeiski ML; Evankovich KD; Armstrong CL; Knight SJ; Wu S; Onar-Thomas A; Gajjar A; Conklin HM
    J Clin Oncol; 2019 Jun; 37(18):1566-1575. PubMed ID: 31046551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
    Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
    JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
    Pulsifer MB; Duncanson H; Grieco J; Evans C; Tseretopoulos ID; MacDonald S; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):391-398. PubMed ID: 30108004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric sensorineural hearing loss is a risk factor for late-onset hearing loss in pediatric cancer survivors following cisplatin treatment.
    Robertson MS; Hayashi SS; Camet ML; Trinkaus K; Henry J; Hayashi RJ
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27494. PubMed ID: 30334605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
    Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
    Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
    J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
    Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
    Bass JK; Hua CH; Huang J; Onar-Thomas A; Ness KK; Jones S; White S; Bhagat SP; Chang KW; Merchant TE
    J Clin Oncol; 2016 Apr; 34(11):1248-55. PubMed ID: 26811531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High occurrence of sleep problems in survivors of a childhood brain tumor with neurocognitive complaints: The association with psychosocial and behavioral executive functioning.
    van Kooten JAMC; Maurice-Stam H; Schouten AYN; van Vuurden DG; Granzen B; Gidding C; de Ruiter MA; van Litsenburg RRL; Grootenhuis MA
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27947. PubMed ID: 31418996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Del Valle Á; Chuang A; Becker A
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balance performance of children and adolescents with sensorineural hearing loss: Repercussions of hearing loss degrees and etiological factors.
    Melo RS; Lemos A; Raposo MCF; Belian RB; Ferraz KM
    Int J Pediatr Otorhinolaryngol; 2018 Jul; 110():16-21. PubMed ID: 29859579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive, academic and functional outcomes in survivors of infant ependymoma (UKCCSG CNS 9204).
    Morrall MCHJ; Reed-Berendt R; Moss K; Stocks H; Houston AL; Siddell P; Picton S; Grundy R
    Childs Nerv Syst; 2019 Mar; 35(3):411-420. PubMed ID: 30554263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.